Wogonoside Attenuates Cutaneous Squamous Cell Carcinoma by Reducing Epithelial–Mesenchymal Transition/Invasion and Cancer Stem-Like Cell Property

PURPOSE: Cutaneous squamous cell carcinoma (cSCC) is the most common second basal cell carcinoma in our population. Wogonoside, the main in vivo metabolite of wogonin, possesses anti-inflammatory, anti-angiogenesis and anti-cancer activities. Nevertheless, the effectiveness of wogonoside therapy on...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiuyong, Chang, Yuan, Gao, Ming, Zhang, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553668/
https://www.ncbi.nlm.nih.gov/pubmed/33116592
http://dx.doi.org/10.2147/OTT.S251806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553668/
https://www.ncbi.nlm.nih.gov/pubmed/33116592
http://dx.doi.org/10.2147/OTT.S251806

Ejemplares similares